RPID Logo

Rapid Micro Biosystems, Inc. (RPID) 

NASDAQ$2.46
Market Cap
$106.36M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
243 of 924
Rank in Industry
33 of 118

RPID Insider Trading Activity

RPID Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$183,0268100
Sells
$000

Related Transactions

Kollender Richard Sdirector1$50,1280$0$50,128
Malloy Kirkdirector1$45,3350$0$45,335
PEI MELINDA LITHERLANDdirector4$41,3630$0$41,363
Spignesi Robert G. Jr.PRESIDENT AND CEO1$38,4000$0$38,400
WIRTJES SEAN MCHIEF FINANCIAL OFFICER1$7,8000$0$7,800

About Rapid Micro Biosystems, Inc.

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) â€¦

Insider Activity of Rapid Micro Biosystems, Inc.

Over the last 12 months, insiders at Rapid Micro Biosystems, Inc. have bought $183,026 and sold $0 worth of Rapid Micro Biosystems, Inc. stock.

On average, over the past 5 years, insiders at Rapid Micro Biosystems, Inc. have bought $1.42M and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kollender Richard S (director) — $50,128. Malloy Kirk (director) — $45,335. PEI MELINDA LITHERLAND (director) — $41,363.

The last purchase of 9,120 shares for transaction amount of $9,484 was made by PEI MELINDA LITHERLAND (director) on 2024‑12‑05.

List of Insider Buy and Sell Transactions, Rapid Micro Biosystems, Inc.

2024-12-05PurchasePEI MELINDA LITHERLANDdirector
9,120
0.0212%
$1.04$9,484+48.54%
2024-12-03PurchasePEI MELINDA LITHERLANDdirector
10,880
0.025%
$1.00$10,880+38.46%
2024-11-27PurchasePEI MELINDA LITHERLANDdirector
19,892
0.0481%
$1.05$20,887+42.41%
2024-11-26PurchasePEI MELINDA LITHERLANDdirector
108
0.0002%
$1.04$112+33.81%
2024-08-08PurchaseMalloy Kirkdirector
50,000
0.123%
$0.91$45,335+21.15%
2024-08-07PurchaseWIRTJES SEAN MCHIEF FINANCIAL OFFICER
10,000
0.0243%
$0.78$7,800+37.33%
2024-08-06PurchaseSpignesi Robert G. Jr.PRESIDENT AND CEO
50,000
0.1147%
$0.77$38,400+31.88%
2024-08-06PurchaseKollender Richard Sdirector
65,000
0.1497%
$0.77$50,128+31.88%
2023-09-06PurchaseWIRTJES SEAN MCHIEF FINANCIAL OFFICER
10,000
0.024%
$0.99$9,894-1.64%
2023-08-15PurchaseSpignesi Robert G. Jr.PRESIDENT AND CEO
20,000
0.046%
$0.97$19,488-4.00%
2023-08-08PurchaseSpignesi Robert G. Jr.PRESIDENT AND CEO
34,000
0.0817%
$0.92$31,447+5.49%
2023-05-17PurchaseSpignesi Robert G. Jr.PRESIDENT AND CEO
20,000
0.0462%
$0.91$18,204+6.58%
2022-06-02PurchaseCHENE DAVID
20,602
0.0446%
$4.66$96,100-62.92%
2022-05-27PurchaseCHENE DAVID
19,414
0.0406%
$4.76$92,407-58.50%
2022-05-25PurchaseCHENE DAVID
12,396
0.0323%
$4.90$60,774-49.44%
2022-05-17PurchaseCHENE DAVID
11,125
0.0243%
$3.94$43,861-43.29%
2022-05-16PurchaseSpignesi Robert G. Jr.President and CEO
10,000
0.0234%
$3.79$37,950-35.86%
2022-03-10PurchaseLOWENSTEIN INESE
10,000
0.0262%
$6.95$69,500-46.34%
2021-07-19PurchaseBain Capital Life Sciences Investors, LLC10 percent owner
100,000
0.2804%
$20.00$2M-59.26%
2021-07-19PurchaseLongitude Capital Partners II, LLC10 percent owner
150,000
0.4205%
$20.00$3M-59.26%
Total: 20
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Spignesi Robert G. Jr.PRESIDENT AND CEO
540012
1.249%
$1.33M50<0.0001%
WIRTJES SEAN MCHIEF FINANCIAL OFFICER
348157
0.8052%
$856,466.2220<0.0001%
Kollender Richard Sdirector
96718
0.2237%
$237,926.2810
Malloy Kirkdirector
64300
0.1487%
$158,178.0010
PEI MELINDA LITHERLANDdirector
54300
0.1256%
$133,578.0040
*Gray background shows insiders who have made transactions during last year

RPID Institutional Investors: Active Positions

Increased Positions8+47.06%206,270+1.17%
Decreased Positions4-23.53%876,129-4.99%
New Positions2New84,618New
Sold Out Positions<1Sold Out547,990Sold Out
Total Postitions21+23.53%17M-3.81%

RPID Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Bain Capital Life Sciences Investors, Llc$25,725.0022.2%8.43M00%2024-12-31
Kennedy Lewis Management Lp$15,067.0013%4.94M00%2024-09-30
Abg-Wtt Global Life Science Capital Partners Gp Ltd$3,167.002.73%1.04M00%2024-12-31
Vanguard Group Inc$2,199.001.9%721,133-5,427-0.75%2024-12-31
Advent International, L.P.$1,762.001.52%577,77700%2024-12-31
Blackrock, Inc.$1,747.001.51%572,87900%2024-12-31
Renaissance Technologies Llc$558.000.48%183,087+100,942+122.88%2024-12-31
Geode Capital Management, Llc$467.000.4%153,112+2,454+1.63%2024-12-31
Citadel Advisors Llc$220.000.19%72,024+72,024New2024-12-31
Millennium Management Llc$187.000.16%61,375+9,191+17.61%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.